References
- Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C, et al. for the American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109:433-8.10.1161/01.CIR.0000111245.75752.C614744958
- Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16:442-3.10.1046/j.1464-5491.1999.00059.x
- Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26:3160-7.10.2337/diacare.26.11.3160
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285: 2486-97.
- Sirdah MM, Abu Ghali AS, Al Laham NA. The reliability of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians. Diabetes Metab Syndr. 2012; 6:4-8.2301424710.1016/j.dsx.2012.05.017
- Rezaianzadeh A, Namayandeh SM, Sadr SM. National cholesterol education program adult treatment panel III vs international diabetic federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?. Int J Prev Med. 2012; 3:552-8.
- Eapen D, Kalra GL, Merchant N, Arora A, Khan B V. Metabolic syndrome and cardiovascular disease in South Asians. Vasc Health Risk Manag. 2009; 5: 731-43.19756165
- Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, et al. Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull. 2008; 31:1475-82.1867007510.1248/bpb.31.1475
- Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999; 99:3110-7.10.1161/01.CIR.99.24.311010377073
- Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008; 409: 349-55.10.1042/BJ2007119618092947
- Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability—analysis in hypercholesterolemic rabbits. Atherosclerosis. 2007; 195:48-56.1723988710.1016/j.atherosclerosis.2006.11.031
- Pirillo A, Catapano AL. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers. 2013; 35:413-8.2419844210.1155/2013/716325
- Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, Sakakibara Y, et al. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol. 2004; 23:111-7.1500075110.1089/104454904322759920
- Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J. 1999; 339:177-84.10.1042/bj339017710085242
- Navarra T, Del Turco S, Berti S, Basta G. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 2010; 17:317-31.10.5551/jat.322820009416
- Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol. 2000; 20:715-20.1071239610.1161/01.ATV.20.3.715
- Brinkley TE, Kume N, Mitsuoka H, Brown MD, Phares DA, Ferrell RE, et al. Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels. Exp Physiol. 2008; 93:1085-90.1846906610.1113/expphysiol.2008.042267
- Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hagberg JM. Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity (Silver Spring). 2008; 16:1454-6.10.1038/oby.2008.21318388896
- Tan KC, Shiu SW, Wong Y, Leng L, Bucala R. Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. J Lipid Res. 2008; 49: 1438-44.10.1194/jlr.M700551-JLR20018408244
- Pongchaiyakul C, Nguyen TV, Kosulwat V, Rojroongwasinkul N, Charoenkiatkul S, Pongchaiyakul C, et al. Defining obesity by body mass index in the Thai population: an epidemiologic study. Asia Pac J Clin Nutr. 2006; 15:293-9.16837420
- Pongchaiyakul C, Nguyen T V, Wanothayaroj E, Karusan N, Klungboonkrong V. Prevalence of metabolic syndrome and its relationship to weight in the Thai population. J Med Assoc Thai. 2007; 90: 459-67.17427521
- Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92:399-404.10.1210/jc.2006-051317284640
- Kobayashi N, Takano M, Hata N, Kume N, Yamamoto M, Yokoyama S, et al. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography. Int J Cardiol. 2013; 168:3217-23.10.1016/j.ijcard.2013.04.11023632121
- Nomata Y, Kume N, Sasai H, Katayama Y, Nakata Y, Okura T, et al. Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men. Metabolism. 2009; 58:1209-14.1959205510.1016/j.metabol.2009.06.018
- Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005; 112:812-8.10.1161/CIRCULATIONAHA.104.46839716061745
- Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—Comparison with other biomarkers. J Cardiol. 2010; 56:159-65.2060569910.1016/j.jjcc.2010.05.002
- Civelek S, Kutnu M, Uzun H, Erdenen F, Altunoglu E, Andican G, et al. Soluble lectin-like oxidized LDL receptor 1 as a possible mediator of endothelial dysfunction in patients with metabolic syndrome. J Clin Lab Anal. 2015; 29:184-90.10.1002/jcla.2174824798146
- Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007; 7:220.1772769710.1186/1471-2458-7-220
- Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome-a pilot study. Circ J. 2010; 74:1399-404.2046715410.1253/circj.CJ-09-0924